Inversago’s drugs use a different approach than most treatments in the obesity and diabetes space.
You are here: Home / Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Market News and Views
Inversago’s drugs use a different approach than most treatments in the obesity and diabetes space.